Your browser doesn't support javascript.
loading
Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study.
Mato, Anthony R; Timlin, Colleen; Ujjani, Chaitra; Skarbnik, Alan; Howlett, Christina; Banerjee, Rahul; Nabhan, Chadi; Schuster, Stephen J.
Afiliación
  • Mato AR; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Timlin C; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Ujjani C; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Chicago, DC, USA.
  • Skarbnik A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Howlett C; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Banerjee R; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Nabhan C; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.
  • Schuster SJ; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Br J Haematol ; 181(2): 259-261, 2018 04.
Article en En | MEDLINE | ID: mdl-28220935

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B Tipo de estudio: Observational_studies Límite: Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B Tipo de estudio: Observational_studies Límite: Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos